chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This study case was received from the investigator in a trial on 28 August 2013. A male subject (date of birth not reported) with no reported past medical history had received on 11 September 2012 ACAM2000 (lot number, route, site and date of administration not reported), Anthrax (lot number, route, site and date of administration not reported), FLUMIST (lot number, route, site and date of administration not reported) and Typhoid (lot number, route, site and date of administration not reported) and five days later on 16 September 2012, experienced moderate chest pain/pressure, shortness of breath and a dry cough while running. The subject stated the events continued intermittently for 48 hours. The subject was reported to have possible myopericarditis. Treatment included one time dose of TYLENOL. On 19 September 2012, Troponin I level was 0.23 ng/ml and an ECG was normal. A Troponin I level on 15 October 2012 was less than 0.10 ng/ml. No further information was available at the time of the report. The subject's outcome was recovered on 18 September 2012. According to the investigator, the event of possible myopericarditis was considered an other important event, possibly related to vaccination and severity of the event was moderate. Documents held by sender: none.
Pt recvd vax 1DEC92 & devel flu-like sx; No further details were provided;
Patient received two doses of Moderna vaccine through different pharmacy (2/16, 3/12). Patient then came to the pharmacy to receive Pfizer vaccine and did not report previous vaccination. After completion of the second vaccine the pharmacist identified that the patient had already received a full course of Moderna vaccine. The patient received Pfizer vaccines from the pharmacy on 5/7 and 5/28. Patient was called and stated to pharmacy staff that he is a scientist and believes that he needed to be vaccinated with the Pfizer and Moderna vaccine to have adequate coverage. Patient noted no adverse effects following vaccination with Pfizer vaccine.
similar symptoms (of COVID); I have a Covid, result came yesterday; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I have a Covid, result came yesterday) and COVID-19 (similar symptoms (of COVID)) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced COVID-19 (I have a Covid, result came yesterday). On an unknown date, the patient experienced COVID-19 (similar symptoms (of COVID)). At the time of the report, COVID-19 (I have a Covid, result came yesterday) and COVID-19 (similar symptoms (of COVID)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications medication were reported. No treatment medications were reported.
developed COVID arm on her left arm.; Itchiness on arm; Redness on arm; Swelling on arm; This spontaneous case was reported by a  and describes the occurrence of VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm). At the time of the report, VACCINATION SITE REACTION (developed COVID arm on her left arm.), VACCINATION SITE PRURITUS (Itchiness on arm), VACCINATION SITE ERYTHEMA (Redness on arm) and VACCINATION SITE SWELLING (Swelling on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to MOD-2021-031866 (Patient Link).
Tingling to tongue and poking to tip of tongue. BP 155/79 (pulse 95), 97% O2 sat. BP 148/76 (pulse 89). Received Benadryl 25 mg PO.
Heart attack; she might have a little bit of heart cell damage; tired; This is a spontaneous report from a contactable nurse (patient). A 73-year-old female patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number: EN6207, Expiration date: Jul2021, NDC number was unknown), via an unspecified route of administration, in right deltoid on 10Mar2021 14:10 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Family medical history relevant to adverse event was not provided. The patient received historical vaccine of first dose bnt162b2 (Lot number: EL9267, Expiration date: May2021) right deltoid on 12Feb2021 for covid-19 immunisation. Patient did not receive prior Vaccinations (within 4 weeks). Caller is a retired Registered Nurse who states she felt it was important to report, that she had a heart attack 70 hours after receiving the Covid vaccine on 13Mar2021. Her doctor informed her she probably should report it. Caller states she's not 100 % sure it's the Covid vaccine. Informs she has no other cardiac issues, health issues or problems with medications, stating they narrowed it down. Patient was taken by ambulance and then to the Emergency Room. States she was admitted to the hospital and had testing done on heart, stress test echo, on heparin IV drip, aspirin. Hospitalized for 4 days. Patient states supposedly she will have a complete recovery, right now she is just tired. Was told she might have a little bit of heart cell damage on an unspecified date in Mar2021, but not anything really significantly. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available. As per the reporter for the heart attack seriousness criteria reported as Life threatening and Caused/prolonged hospitalization. patient was in hospital for Heart attack from 13Mar2021 to 16Mar2021. As per the reporter drug result reporter as related. The patient underwent lab tests and procedures which included testing done on heart and stress test echo with unknown results in 2021. Therapeutic measures were taken as a result of heart attack. The outcome of the events was unknown.; Sender's Comments: Based on known drug safety profile, there is possibility of causal association between the reported events Heart attack,Heart injury and the suspect vaccine BNT162B2 cannot be Excluded.Also there is limited information in the case provided,Consider also possible contributory effects from patient's medical history and surgical history.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
A few minutes after the injection the patient started to feel dizzy and panicked feeling she tried to stand up and blacked out for an instant.  She also noted spasms in her left arm . Clammy , pale.  She recovered over 10 minutes or so and felt completely normal.  Left with her friend driving her.
Was given a Moderna Vaccine following a Pfizer vaccine in January.  Had side-effects about 8 hours after vaccine to include chills and side effects.  This lasted 1.5 days.  Next seven days were normal, then started freezing, headaches, muscles aches, fatigue., which lasted two days.  Still have ongoing headaches, this is day six of the headaches.
Initial report received from a reporter on 24 OCTOBER 2013. Sixteen adult patients had received FLUZONE MDV (lot # UH900AD and expiration date unknown) right/left deltoid on past two weeks. On 24 OCT 2013 within 24 hours, the patients reported about severe arm pain in the whole arm that they received the vaccine and one patient, had a knot in her arm. Some had some redness and swelling. At the time of the report, the outcome of the event was unknown. No further relevant information reported.
Sudden onset of Atrial Flutter early in the morning of 9/14, heart palpitations, high resting heart rate (130-140), BP readings all over the place (high and low), some dizziness on rising to a standing position, feeling weak, sweating.  This continued throughout the day and I decided to go to the ER as it wasn't subsiding.  A second episode occurred later that week on 9/16/21.  Both were treated with electrical cardioversion. While now back in regular sinus rhythm, unknown whether this is now under control, ablation surgery for A-flutter is recommended.
Pain at injection site (2 deltoid) beginning 90 min after injection with motor weakness of deltoid for next 48 hours.
Administered to an LPN at the Personnel Health on 11/20/2013. Area became red & puffy. Showed the area to a PA on 11/23. He said it was a hive. 11/23 Took diphenhydramine 25 mg po X1. 11/27 Area still sore & has tingling in fingers.
almost exactly one month after second dose I began to experience extreme anxiety and panic attacks.  I could not get out of bed for 5 days straight.  I could not eat or drink or sleep more than short periods of time before a panic attack would wake me.  My tinnitus which had never disabled me before was unbearable.  Since April I have still been battling anxiety and panic attacks but I have also developed ear pressure and pain, extreme dizziness/vertigo, extreme sensitivity to sound, and constant fatigue.  I also have periods of mild numbness and tingling sensations down my right leg and right arm.
Chills and extreme shivering. Low temperature (97) moving to above 101. Increased heart rate (55->100). Better by 7:00 PM.
The vaccine improperly stored in the freezer instead of the 2-25 degrees Celsius as noted on the packaging.
This consumer report (initial receipt 26-Sep-2013) concerns a 21-year-old female patient. On an unspecified date ('one year ago' from initial reporting), the patient received a one-time injection of unspecified flu vaccine (manufacturer and batch number not reported) that she was 'forced to get'. On an unspecified date ('about one year ago' from initial reporting), the patient developed Multiple Sclerosis. The patient sought medical attention through a doctor's visit. The patient underwent the laboratory diagnostic study of 'Litnia test'. Outcome was reported as not yet recovered. (Linked to TC-704).
pt started not feeling well 21OCT95 in early afternoon; By 22OCT having achiness which still cont;By first part of wk 23OCT & 24OCT started w/runny nose & congestion which still cont;unsure if ran fever;
Are people experiencing respiratory issues weeks after getting the vaccine?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY SYMPTOM (Are people experiencing respiratory issues weeks after getting the vaccine?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RESPIRATORY SYMPTOM (Are people experiencing respiratory issues weeks after getting the vaccine?). At the time of the report, RESPIRATORY SYMPTOM (Are people experiencing respiratory issues weeks after getting the vaccine?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient's information were not provided.  Concomitant medications were not provided.  Treatment medications was not given.
As I walked from the pharmacy out the front door of the store I started sneezing over and over again. Then I felt as if my veins where being restricted. It started in my head moved to eyes then my sinus', moved to my ears then to the throat and moved down to about my chest bone. At that point it seemed to stop moving threw my body. As my body kept reacting I had shortness of breath and it continued to be harder to breathe. Then right between my breasts there started a pain that I can only discribe as feeling like a severe acid reflux pain at which point I started drinking water every few minutes and it helped me breathe better. My husband needed to stop at a store that was about 30 minutes away and ... cont. below asked me to walk inside with him to keep an eye on me. Slowly the restricted feeling started to subside and  within an hour I felt back to normal.   The next morning 9/27/2023 I woke up with a sore arm and my head has a fullness feeling as well as feeling physically tired.
BECAME SO NERVOUS; This spontaneous report received from a patient via a company representative through social media concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient was previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. It was unknown whether patient had any adverse events following covid-19 vaccine (Dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin, batch number and expiry were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, following vaccination with second dose the patient became so nervous, had to hold glass with both hands in order to drink (Dose number in series 2). It was reported as "After receiving my second j j shot, I became so nervous had to hold my glass with both hands in order to drink, still that way. No more shots for me." (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from became so nervous. This report was non-serious.
Lungs hurt, itching all over but no visible hives, dizzy, sharp pain in lungs, difficulty inhaling
Pt kept sticking her tongue out in a weird manner when she would scream and the left leg felt pretty warm at the injection site. Pt was not willing to walk after injection, and screamed as if in pain for over an hour after injection.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 30-DEC-2017, the patient was vaccinated with an improperly storage dose of PROQUAD, lot # N023967, expiration date 28-FEB-2019, (dose number, dose, and route were not reported), for prophylaxis. Other suspect therapies included sterile diluent (MERCK), (Lot number N027626 Expiration date 20-MAY-2019). The PROQUAD and the sterile diluent (MERCK) was on a temperature excursion from 6 to 14 Fahrenheit Degrees during 1 hour and 18 minutes; and from 15 to 46 Fahrenheit Degrees during 34 hours and 29 minutes. Both products had multiple previous temperature excursions. The digital data logger was involved. No adverse effects or reactions had been reported. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1801USA005276.
Onset of fevers up to 103 for 4 days. Assoc with irritability. Evaluated in Primary Care Office x 2. CBC reassuring. Bld Culture, urine culture, sent R/O infectious cause of fever.
No additional AE reported; a dose of PROQUAD that experienced a temperautre excursion was administered to the patient after the excursion occured; This spontaneous report was received from a medical assistant and referred to a patient of unknown age and gender. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported.  On 15-JUN-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine (live recombinant human albumin (rHA)) (PROQUAD) subcutaneous injection (0.5 milliliter, lot #U039262, expiration date: 09-JUN-2023) administered for prophylaxis (strength, and route of administration were not provided) (product storage error).  It was reported that the suspect vaccine was exposed to a temperature of 7.7 Fahrenheit (F) for a time frame of 30 minutes. There was previous temperature excursion.  No additional adverse event was reported.   This is one of the several report received from the same reporter.; Sender's Comments:  US-009507513-2206USA007839: US-009507513-2206USA007845:
Patient suffered a stroke, a large-vessel occlusion, an M1  occlusion with large area infarct, he has sever left sided weakness, left facial droop, is unable to swallow well enough to eat or drink safely, he is unable to walk and has expressive aphasia and slurred speech.
Body aches, low grade fever (99.8), chills, headache, 6cm induration @ injection site with redness, warmth, pain and swelling. Sx developed by 2100 day of injection. 24-60hours post injection- continued all Sx as above with development of fatigue, development of sharp, stabbing left lateral torso pain (under lower ribs,) and worsening arm pain (throbbing) and increased area of redness and warmth. 60+ hours post injection -body aches abated, headache abated, side pain lessened in frequency, local arm reaction continued and itching began.
Reports a  few hours after receiving the flu shot noted pain in the joint. Rated the pain at a level of 6 (six) on a scale of 1-10 where 10 is the worst pain. Took Tylenol and took Ibuprofen a few hours after that. Reported medication helped but reported she experienced more weakness in her arm. Reported has an appointment to see MD on 12/02/2014.  Reported pain comes and goes.  Reports disconfort in the joint - points to shoulder joint in upper arm. Reports sometimes experiences weakness in hand.
mom states pt had seizures x 2 p/SEPT vax; pt seen by MD & hospitalized & is on an apnea monitor @ this time;
heart fluttering; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients (herself and her husband). This is the 2nd of 2 reports (husband).  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Mar2021 (Batch/Lot number was not reported) as single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that after receiving the vaccines on 11Mar2021, on the drive home after the 15-minute waiting period the patient developed heart fluttering. The outcome of event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021314332 same reporter, product and event, different patient
On evaluation, pt was noted to be in mod discomfort w/ conj/nasal congestion, dry cough but no acute sob. Exam significant for mild diffuse exp wheeze, o/w normal. Patient was referred to Urgent Care for immediate treatment and his primary care physician was notified.
Generalized pain and swelling of 3" x 3" in L tricep area. Site showed no redness, duration x 2 days, character is constant, alleviating factors: nothing, exacerbating factors: moving and lifting. Treatment: ice and Naproxen, 500 mg PO BID, PRN # 20.
Pain and stiffness-neck when turning head to right, R arm pain, unable to lift past shoulder height after receiving hep B vaccine R deltoid 2/2/04. Muscle reaction from injection.
Post vaccine administration, pt developed hives, decreased O2 sats, swelling in face and elbows. O2 administered in office along with BENADRYL and EPIPEN prior to transport to ER.
Information has been received from a pharmacist concerning a female who was vaccinated IM with a dose of Gardasil.  Subsequently the patient experienced weakness and numbness in the arm the injection was given.  The patient was also not as talkative as she normally is.  It was unknown whether medical attention was sought.  The patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
This was my booster.  Morning after had slight fever with body aches so bad I could not touch my skin.  Slept all day and that night.  After 24 hours my left arm started to swell and was very sore to touch and raise up.  30 hours post shot, my arm started to get red and itch.  second day post shot arm is still swolen and red but no itch.  Treated all symptoms with tylenol and ibuprofen   I have this type of reaction with other shots incluyding flu, shingles and the first moderna injection.  Nothing after second injection.,
patient was administered boostrix on 6/26 and syringe leaked; patient was administered boostrix on 6/26 and syringe leaked; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 33-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 575hc, expiry date 28th February 2023) for prophylaxis.   Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 26th June 2021, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 26th June 2021, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced accidental underdose and syringe leak. On an unknown date, the outcome of the accidental underdose and syringe leak were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided are as follows: The age at vaccination was not reported. The registered pharmacist reported that the patient was administered with Boostrix and syringe leaked which led to accidental underdose and syringe leak. The reporter asked for the dose re administration. No product quality complaint was reported. The reporter consented to follow up.
No adverse effects were reported; Received a dose of MMRII that was reconstituted with a expired diluent; This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 06-MAR-2019, the patient was vaccinated with a dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) one dose, for prophylaxis (strength, frequency, route of administration, lot number and expiration date were not reported). The vaccine was reconstituted with an expired sterile diluent (MERCK STERILE DILUENT) lot #M016884 and expiration date 04-DEC-2018 (strength, frequency, and route of administration were not reported). No adverse effects.   This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA008859:
I received the high dose vax in my left arm. A couple of days after the injection my arm in that area became sore. The soreness was intermittent and came and went. I still have the soreness but it's not that sore as it was. It seems to come in on that area after exercising and inclement weather.